Dow Up 0.27% Nasdaq Down 0.23%

Sorrento Therapeutics, Inc. (SRNE)

-NasdaqCM
4.95 Up 0.08(1.64%) 3:44PM EDT - Nasdaq Real Time Price
Prev Close:4.87
Open:4.79
Bid:4.91 x 500
Ask:4.95 x 600
1y Target Est:20.67
Beta:2.47
Next Earnings Date:N/A
Day's Range:4.77 - 4.95
52wk Range:4.27 - 16.40
Volume:78,800
Avg Vol (3m):84,675
Market Cap:141.23M
P/E (ttm):N/A
EPS (ttm):-1.66
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SRNE

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):71.80
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.43
Quarterly EPS Est (Sep-14) :-0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sorrento Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States, Europe, and internation... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback